Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis

被引：58

作者：

Jinnin, Masatoshi ^{[1
]}

Yamamoto, Toshiyuki ^{[2
]}

Asano, Yoshihide ^{[3
]}

Ishikawa, Osamu ^{[4
]}

Sato, Shinichi ^{[3
]}

Takehara, Kazuhiko ^{[5
]}

Hasegawa, Minoru ^{[6
]}

Fujimoto, Manabu ^{[7
]}

Ihn, Hironobu ^{[1
]}

机构：

[1] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan

[2] Fukushima Med Univ, Sch Med, Dept Dermatol, Fukushima, Japan

[3] Univ Tokyo Hosp, Dept Dermatol, Tokyo, Japan

[4] Gunma Univ, Grad Sch Med, Dept Dermatol, Gunma, Japan

[5] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Med, Dept Mol Pathol Skin, Kanazawa, Ishikawa, Japan

[6] Univ Fukui, Fac Med Sci, Div Med, Dept Dermatol Div, Fukui, Japan

[7] Univ Tsukuba, Fac Med, Dept Dermatol, Tsukuba, Ibaraki, Japan

来源：

JOURNAL OF DERMATOLOGY | 2018年 / 45卷 / 08期

关键词：

collagen; eosinophils; fibrosis; guideline; skin; OF-THE-LITERATURE; SEVERE APLASTIC-ANEMIA; BONE-MARROW-TRANSPLANTATION; ANTITHYMOCYTE GLOBULIN; CAPILLARY MICROSCOPY; SYSTEMIC-SCLEROSIS; SHULMANS-SYNDROME; D-PENICILLAMINE; CYCLOSPORINE-A; SCLERODERMA;

D O I：

10.1111/1346-8138.14160

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

We established diagnostic criteria and severity classification of eosinophilic fasciitis because there is no established diagnostic criteria or widely accepted severity classification of the disease. Also, there has been no clinical guideline for eosinophilic fasciitis, so we established its clinical guideline ahead of all over the world. In particular, the clinical guideline was established by clinical questions based on evidence-based medicine according to the New Minds Clinical Practice Guideline Creation Manual (version 1.0). We aimed to make the guideline easy to use and reliable based on the newest evidence, and to present guidance as specific as possible for various clinical problems in treatment of eosinophilic fasciitis.

引用

页码：881 / 890

页数：10

共 85 条

[1] EOSINOPHILIC FASCIITIS IN AN AFRICAN - POSSIBLE BENEFIT OF CHLOROQUINE TREATMENT [J].

ALLEN, SC .

POSTGRADUATE MEDICAL JOURNAL, 1984, 60 (708) :685-686

[2] Eosinophilic fasciitis/generalized morphea overlap successfully treated with azathioprine [J].

Alonso-Castro, Leticia ;

de las Heras, Elena ;

Moreno, Carmen ;

Fleta-Asin, Beatriz ;

Munoz-Zato, Ernesto ;

Carrillo, Rosario ;

Jaen, Pedro .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (11) :1386-1388

[3] Eosinophilic fasciitis 30 years after - What do we really know? Report of 11 patients and review of the literature [J].

Antic, Milos ;

Lautenschlager, Stephan ;

Itin, Peter H. .

DERMATOLOGY, 2006, 213 (02) :93-101

[4] Eosinophilic fasciitis following idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia and Hashimoto's disease [J].

Bachmeyer, C ;

Monge, M ;

Dhôte, R ;

Sanguina, M ;

Aractingi, S ;

Mougeot-Martin, M .

DERMATOLOGY, 1999, 199 (03) :282-282

[5]

BARNES L, 1979, AM J PATHOL, V96, P493

[6] MRI for diagnosis and monitoring of patients with eosinophilic fasciitis [J].

Baumann, F ;

Brühlmann, P ;

Andreisek, G ;

Michel, BA ;

Marincek, B ;

Weishaupt, D .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (01) :169-174

[7] Eosinophilic fasciitis: clinical characteristics and response to methotrexate [J].

Berianu, Florentina ;

Cohen, Marc D. ;

Abril, Andy ;

Ginsburg, William W. .

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (01) :91-98

[8]

Bischoff L, 2008, INT J DERMATOL, V47, P29, DOI 10.1111/j.1365-4632.2007.03544.x

[9]

BLASER KU, 1989, SCHWEIZ MED WSCHR, V119, P1899

[10]

Bonnotte B, 1998, BRIT J RHEUMATOL, V37, P1358

← 1 2 3 4 5 6 7 8 9 →